Kornitzer Capital Management Inc. KS Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN

Kornitzer Capital Management Inc. has initiated a new position in Regeneron Pharmaceuticals, Inc. ($REGN) during the fourth quarter, acquiring 1,891 shares valued at approximately $1.46 million. This move comes as Regeneron reported strong Q1 results, with EPS topping estimates and revenue increasing by 19% year-over-year, alongside announcing a $3 billion share buyback and a quarterly dividend. Despite positive earnings and several analyst target increases, the stock experienced a mixed market reaction, with some firms trimming forecasts and insiders reducing their holdings recently.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin